The origins of '5-HT and mechanisms of defence' by Deakin and Graeff: A personal perspective

Journal of Psychopharmacology

Volumn 27, Issue 12, 2013, Pages 1084-1089

  Deakin, J F W ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

5 HT; aversion; neurobiology; stress

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; DOPAMINE; FLUOXETINE; RITANSERIN; SEROTONIN; SEROTONIN 2C RECEPTOR; SEROTONIN UPTAKE INHIBITOR;

AMYGDALOID NUCLEUS; ANTICIPATORY ANXIETY; ANXIETY DISORDER; AVERSION; DEFENSE MECHANISM; DEPRESSION; DORSAL RAPHE NUCLEUS; ELECTRODERMAL RESPONSE; ESCAPE BEHAVIOR; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; LEARNED HELPLESSNESS; MEDIAN RAPHE NUCLEUS; MEMORY CONSOLIDATION; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; NERVE PROJECTION; NEUROMODULATION; NEUROPHARMACOLOGY; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; PROTEIN FUNCTION; PSYCHOPHARMACOLOGY; PUNISHMENT; REVIEW; REWARD; SEROTONIN DOPAMINE OPPONENCY; SEROTONINERGIC TRANSMISSION; THEORY; TRANSLATIONAL RESEARCH; ANIMAL; AVOIDANCE BEHAVIOR; HISTORY; METABOLISM; PHYSIOLOGY; PROCEDURES;

ANIMALS; AVOIDANCE LEARNING; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; PSYCHOPHARMACOLOGY; REWARD; SEROTONIN;

EID: 84887850502     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881113503508     Document Type: Review

References (60)

1. Adolphs R. The biology of fear. Curr Biol. 2013 ; 23: R79-93
2. Amat J, Baratta MV, Paul E, et al. Medial prefrontal cortex determines how stressor controllability affects behavior and dorsal raphe nucleus. Nat Neurosci. 2005 ; 8: 365-371
3. Arango V, Underwood MD, Boldrini M, et al. Serotonin 1A receptors, serotonin transporter binding and serotonin transporter mRNA expression in the brainstem of depressed suicide victims. Neuropsychopharmacology. 2001 ; 25: 892-903
4. Ashcroft KR, Guimarães FS, Wang M, et al. Evaluation of a psychophysiological model of classical fear conditioning in anxious patients. Psychopharmacology (Berl). 1991 ; 104: 215-219
5. Azmitia EC, Segal M. An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J Comp Neurol. 1978 ; 179: 641-667
6. Bach-Mizrachi H, Underwood MD, Tin A, et al. Elevated expression of tryptophan hydroxylase-2 mRNA at the neuronal level in the dorsal and median raphe nuclei of depressed suicides. Mol Psychiatry. 2008 ; 13: 507-513
7. Barton DA, Esler MD, Dawood T, et al. Elevated brain serotonin turnover in patients with depression: Effect of genotype and therapy. Arch Gen Psychiatry. 2008 ; 65: 38-46
8. Blanchard R, Blanchard D. Defensive reactions in the albino rat. Learn Motiv. 1971 ; 2: 351-362
9. Boldrini M, Underwood MD, Mann JJ, et al. More tryptophan hydroxylase in the brainstem dorsal raphe nucleus in depressed suicides. Brain Res. 2005 ; 1041: 19-28
10. Boldrini M, Underwood MD, Mann JJ, et al. Serotonin-1A autoreceptor binding in the dorsal raphe nucleus of depressed suicides. J Psychiatr Res. 2008 ; 42: 433-442
11. Bonkale WL, Turecki G, Austin MC. Increased tryptophan hydroxylase immunoreactivity in the dorsal raphe nucleus of alcohol-dependent, depressed suicide subjects is restricted to the dorsal subnucleus. Synapse. 2006 ; 60: 81-85
12. Boureau YL, Dayan P. Opponency revisited: Competition and cooperation between dopamine and serotonin. Neuropsychopharmacology. 2011 ; 36: 74-97
13. Burghardt NS, Bush DE, McEwen BS, et al. Acute selective serotonin reuptake inhibitors increase conditioned fear expression: Blockade with a 5-HT(2C) receptor antagonist. Biol Psychiatry. 2007 ; 62: 1111-1118
14. Campbell BM, Merchant KM. Serotonin 2C receptors within the basolateral amygdala induce acute fear-like responses in an open-field environment. Brain Res. 2003 ; 993: 1-9
15. Christianson JP, Ragole T, Amat J, et al. 5-hydroxytryptamine 2C receptors in the basolateral amygdala are involved in the expression of anxiety after uncontrollable traumatic stress. Biol Psychiatry. 2010 ; 67: 339-345
16. Cools R, Nakamura K, Daw ND. Serotonin and dopamine: Unifying affective, activational, and decision functions. Neuropsychopharmacology. 2011 ; 36: 98-113
17. Cools R, Roberts AC, Robbins TW. Serotonergic regulation of emotional and behavioural control processes. Trends Cogn Sci. 2008 ; 12: 31-40
18. Crockett MJ, Clark L, Robbins TW. Reconciling the role of serotonin in behavioral inhibition and aversion: Acute tryptophan depletion abolishes punishment-induced inhibition in humans. J Neurosci. 2009 ; 29: 11993-11999
19. Crockett MJ, Clark L, Apergis-Schoute AM, et al. Serotonin modulates the effects of Pavlovian aversive predictions on response vigor. Neuropsychopharmacology. 2012 ; 37: 2244-2252
20. Crow TJ. Catecholamine-containing neurones and electrical self-stimulation. 2. A theoretical interpretation and some psychiatric implications. Psychol Med. 1973 ; 3: 66-73
21. Daw ND, Kakade S, Dayan P. Opponent interactions between serotonin and dopamine. Neural Netw. 2002 ; 15: 603-616
22. Deakin JFW Theory in Psychopharmacology. 1983 ) Roles of serotonergic systems in escape, avoidance and other behaviours. In: CooperSJ (ed) Theory in Psychopharmacology. Vol 2, 2nd ed.New York: Academic Press. pp. 149-193. Cooper SJ, ed. New York: Academic Press ; 1983: 149-193.
23. Deakin JF. 5HT2 receptors, depression and anxiety. Pharmacol Biochem Behav. 1988 ; 29: 819-820
24. Deakin JF. 5-HT, antidepressant drugs and the psychosocial origins of depression. J Psychopharmacol. 1996 ; 10: 31-38
25. Deakin JFW, Graeff FG. 5-HT and mechanisms of defence. J Psychopharmacol. 1991 ; 5: 305-316
26. Deakin JF, Pennell I, Upadhyaya AJ, et al. A neuroendocrine study of 5HT function in depression: Evidence for biological mechanisms of endogenous and psychosocial causation. Psychopharmacology (Berl). 1990 ; 101: 85-92
27. Dekeyne A, Denorme B, Monneyron S, et al. Citalopram reduces social interaction in rats by activation of serotonin (5-HT)(2C) receptors. Neuropharmacology. 2000 ; 39: 1114-1117
28. De Montigny C, Blier P. Effects of antidepressant treatments on 5-HT neurotransmission: Electrophysiological and clinical studies. Adv Biochem Psychopharmacol. 1984 ; 39: 223-239
29. Elliott R, Zahn R, Deakin JFW, et al. Affective cognition and its disruption in mood disorders. Neuropsychopharmacology. 2011 ; 36: 153-182
30. Feinstein JS, Buzza C, Hurlemann R, et al. Fear and panic in humans with bilateral amygdala damage. Nat Neurosci. 2013 ; 16: 270-272
31. Graeff FG, Schoenfeld RI. Tryptaminergic mechanisms in punished and nonpunished behavior. J Pharmacol Exp Ther. 1970 ; 173: 277-283
32. Guimarães FS, Hellewell J, Hensman R, et al. Characterization of a psychophysiological model of classical fear conditioning in healthy volunteers: Influence of gender, instruction, personality and placebo. Psychopharmacology (Berl). 1991 ; 104: 231-236
33. Guimarães FS, Mbaya PS, Deakin JF. Ritanserin facilitates anxiety in a simulated public-speaking paradigm. J Psychopharmacol. 1997 ; 11: 225-231
34. Harmer CJ, Cowen PJ. 'It's the way that you look at it'-a cognitive neuropsychological account of SSRI action in depression. Philos Trans R Soc Lond B Biol Sci. 2013 ; 368: 20120407
35. Hellewell JS, Guimaraes FS, Wang M, et al. Comparison of buspirone with diazepam and fluvoxamine on aversive classical conditioning in humans. J Psychopharmacol. 1999 ; 13: 122-127
36. Hensman R, Guimarães FS, Wang M, et al. Effects of ritanserin on aversive classical conditioning in humans. Psychopharmacology (Berl). 1991 ; 104: 220-224
37. Hetem LA, de-Souza CJ, Guimarães FS, et al. D-fenfluramine reduces anxiety induced by simulated public speaking. Braz J Med Biol Res. 1993 ; 26: 971-974
38. Hindi Attar C, Finckh B, Büchel C. The influence of serotonin on fear learning. PLoS One. 2012 ; 7 (8). e42397
39. Janssen PA. Pharmacology of potent and selective S2-serotonergic antagonists. J Cardiovasc Pharmacol. 1985 ;: S2-11
40. Joca SR, Padovan CM, Guimarães FS. Activation of post-synaptic 5-HT(1A) receptors in the dorsal hippocampus prevents learned helplessness development. Brain Res. 2003 ; 978: 177-184
41. Kennett GA, Dickinson SL, Curzon G. Enhancement of some 5-HT-dependent behavioural responses following repeated immobilization in rats. Brain Res. 1985 ; 330: 253-263
42. Kennett GA, Dourish CT, Curzon G. Antidepressant-like action of 5-HT1a agonists and conventional antidepressants in an animal model of depression. Eur J Pharmacol. 1987 ; 134: 265-274
43. Kiser RS, German DC, Lebovitz RM. Serotonergic reduction of dorsal central gray area stimulation-produced aversion. Pharmacol Biochem Behav. 1978 ; 9: 27-31
44. Maier SF, Watkins LR. Stressor controllability and learned helplessness: The roles of the dorsal raphe nucleus, serotonin, and corticotropin-releasing factor. Neurosci Biobehav Rev. 2005 ; 29: 829-841
45. Matthews PR, Harrison PJ. A morphometric, immunohistochemical, and in situ hybridization study of the dorsal raphe nucleus in major depression, bipolar disorder, schizophrenia, and suicide. J Affect Disord. 2012 ; 137: 125-134
46. Mayberg HS, Brannan SK, Tekell JL, et al. Regional metabolic effects of fluoxetine in major depression: Serial changes and relationship to clinical response. Biol Psychiatry. 2000 ; 48: 830-843
47. McKie S, Richardson P, Elliott R, et al. Mirtazapine antagonises the subjective, hormonal and neuronal effects of m-chlorophenylpiperazine (mCPP) infusion: A pharmacological-challenge fMRI (phMRI) study. Neuroimage. 2011 ; 58: 497-507
48. Mobbs D, Petrovic P, Marchant JL, et al. When fear is near: Threat imminence elicits prefrontal-periaqueductal gray shifts in humans. Science. 2007 ; 317: 1079-1083
49. Mortimore C, Anderson IM. d-Fenfluramine in panic disorder: A dual role for 5-hydroxytryptamine. Psychopharmacology (Berl). 2000 ; 149: 251-258
50. Ogren SO, Eriksson TM, Elvander-Tottie E, et al. The role of 5-HT(1A) receptors in learning and memory. Behav Brain Res. 2008 ; 195: 54-77
51. Paul ED, Lowry CA. Functional topography of serotonergic systems supports the Deakin/Graeff hypothesis of anxiety and affective disorders. J Psychopharmacol. 2013 ;:
52. Sara SJ. Reactivation, retrieval, replay and reconsolidation in and out of sleep: Connecting the dots. Front Behav Neurosci. 2010 ; 4: 1-5
53. Schütz MT, de Aguiar JC, Graeff FG. Anti-aversive role of serotonin in the dorsal periaqueductal grey matter. Psychopharmacology (Berl). 1985 ; 85: 340-345
54. Seymour B, Daw ND, Roiser JP, et al. Serotonin selectively modulates reward value in human decision-making. J Neurosci. 2012 ; 32: 5833-5842
55. Sharp T, Cowen PJ. 5-HT and depression: Is the glass half-full?. Curr Opin Pharmacol. 2011 ; 11: 45-51
56. Soubrié P. Reconciling the role of central serotonin neurons in human and animal behaviour. Behav Brain Sci. 1986 ; 9: 319-364
57. Strickland PL, Deakin JF, Percival C, et al. Bio-social origins of depression in the community. Interactions between social adversity, cortisol and serotonin neurotransmission. Br J Psychiatry. 2002 ; 180: 168-173
58. Tanaka SC, Shishida K, Schweighofer N, et al. Serotonin affects association of aversive outcomes to past actions. J Neurosci. 2009 ; 29: 15669-15674
59. Underwood MD, Khaibulina AA, Ellis SP, et al. Morphometry of the dorsal raphe nucleus serotonergic neurons in suicide victims. Biol Psychiatry. 1999 ; 46: 473-483
60. Wise CD, Berger BD, Stein L. Serotonin: A possible mediator of behavioural suppression induced by anxiety. Dis Nerv Syst. 1970 ; 31: 34-37